Shape as an Independent Design Parameter for Blood–Brain Barrier Crossing: Anisotropic Nanoparticles in Neurodegenerative Diseases
Pharmaceutics · 10.11.2026 · 18 (11) · 1453
DOI: 10.3390/pharmaceutics18111453 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 10.11.2026. Verfasst von Egor A. Turovsky. Die Arbeit nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State assignment.
Abstract (Originalsprache)
Background
Neurodegenerative diseases (NDDs) impose a growing burden, yet effective therapy remains limited because the blood–brain barrier (BBB) restricts CNS drug delivery. Existing reviews treat particle geometry as secondary to composition, size, and surface functionalization.
Objectives
This review examines shape anisotropy as an independent design parameter for BBB crossing, arguing that non-spherical geometry qualitatively changes the logic of particle–barrier interaction.
Methods
As a narrative review, it synthesizes studies comparing anisotropic and spherical particles of comparable size and surface chemistry, with emphasis on mechanistic evidence linking geometry to transport.
Findings
Geometry governs adhesion under flow, membrane wrapping, endocytic route multiplicity, and intracellular trafficking. A barrier-crossing versus penetration-depth trade-off is identified: efficient transcytosis and deep parenchymal distribution are mutually exclusive. The same anisotropy that enhances BBB interaction also reduces its predictability—the “paradox of shape”—owing to the protein corona, endothelial heterogeneity, and disease-altered barrier status.
Conclusions
Shape is not a universal “key to the BBB” but a controllable, context-dependent parameter, shifting the field from an optimal geometry toward disease-oriented, robustness-based design.
Förderung
- State assignment
Zitieren
APA
Turovsky, E. A. (2026). Shape as an Independent Design Parameter for Blood–Brain Barrier Crossing: Anisotropic Nanoparticles in Neurodegenerative Diseases. Pharmaceutics, 18(11), 1453. https://doi.org/10.3390/pharmaceutics18111453
Vancouver
Turovsky EA. Shape as an Independent Design Parameter for Blood–Brain Barrier Crossing: Anisotropic Nanoparticles in Neurodegenerative Diseases. Pharmaceutics. 2026;18(11):1453. doi:10.3390/pharmaceutics18111453
BibTeX
@article{Turovsky2026,
author = {Turovsky, Egor A.},
title = {Shape as an Independent Design Parameter for Blood–Brain Barrier Crossing: Anisotropic Nanoparticles in Neurodegenerative Diseases},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {11},
pages = {1453},
doi = {10.3390/pharmaceutics18111453}
}
EUVIMED